Singapore Researchers Develop a Bio-functional Thermogel to Prevent Retinal Scarring

Singapore scientists have developed a bio-functional thermogel, a type of synthetic polymer, to prevent retinal scarring caused by failed retinal detachment repair surgery.

Singapore Researchers Develop a Bio-functional Thermogel to Prevent Retinal Scarring
July 05, 2022
Measuring Levels of Proteins in Eye Fluid May Accurately Predict Need for Lifelong Macular Degeneration Therapy

In a study of eye fluid from 38 patients, Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong...

Measuring Levels of Proteins in Eye Fluid May Accurately Predict Need for Lifelong Macular Degeneration Therapy
July 04, 2022
Adverum Biotechnologies Granted PRIME Designation by EMA for ADVM-022 in Wet AMD

Adverum Biotechnologies announced that the European Medicines Agency (EMA) has granted ADVM-022 Priority Medicines (PRIME) designation for the treatment of wet age-related macular degeneration (AMD).

Adverum Biotechnologies Granted PRIME Designation by EMA for ADVM-022 in Wet AMD
July 01, 2022
The Vision Council Concludes Successful 2022 National Sunglasses Day Campaign

Every day millions of Americans make the conscious decision to not wear sunglasses or other ultraviolet (UV) protective eyewear. While seemingly harmless, this habit carries serious vision risks, many of which are not known or understood by those who fail

The Vision Council Concludes Successful 2022 National Sunglasses Day Campaign
July 01, 2022
Walmart is acquiring Memomi, an AR startup powering virtual try-on for eyewear

Walmart is expanding its array of virtual try-on services for shoppers with today’s news that it’s acquiring Memomi.

Walmart is acquiring Memomi, an AR startup powering virtual try-on for eyewear
June 30, 2022
Ocuphire Granted New US Patent for Late-Stage Oral Drug Candidate for Use in Diabetic Eye Disease

Ocuphire Pharma announced that the United States Patent and Trademark Office (USPTO) has issued a new patent extending expiry and broadening coverage of the company’s late-stage oral product candidate, APX3330, for diabetic eye disease.

Ocuphire Granted New US Patent for Late-Stage Oral Drug Candidate for Use in Diabetic Eye Disease
June 30, 2022
Europe Grapples with Shortage in OVD Supply, Major Producers Affected

Supply tightness in Ophthalmic Viscoelastic Devices, also known as OVDs, has gripped the European market, according to industry sources. Ophthalmology Breaking News reached sources familiar with the matter, and examined the reasons behind this crippling..

Europe Grapples with Shortage in OVD Supply, Major Producers Affected
June 29, 2022
Ray-Ban's billionaire owner Leonardo Del Vecchio passes away at 87

Raised in a Milan orphanage, Del Vecchio struck out from the northern city to set up shop in the town of Agordo, in the Alps north of Venice, starting off as a small supplier of frame parts

Ray-Ban's billionaire owner Leonardo Del Vecchio passes away at 87
June 29, 2022
New Deep-Learning Resource Model Can Identify Many Common Eye Diseases

The automation of disease diagnosis relies on deep learning models that can accurately and efficiently identify measurements of tumors, tissue volume, or other types of abnormalities.

New Deep-Learning Resource Model Can Identify Many Common Eye Diseases
June 28, 2022
Eye Movements May Be Missing in Our Understanding of Memory

Humans have a fascinating ability to recreate events in the mind's eye, in exquisite detail. Over 50 years ago, Donald Hebb and Ulrich Neisser, the forefathers of cognitive psychology, theorized that eye movements are vital for our ability to do this.

Eye Movements May Be Missing in Our Understanding of Memory
June 28, 2022
Daha fazla